Antidote Therapeutics
MD - SykesvilleBiotechnology
Focus: Antidote Therapeutics is a early-stage biotechnology company focused on nicotine-blocking therapies, headquartered in Sykesville, Maryland. The company is at a nascent stage with minimal public operational data.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About Antidote Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow Antidote Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Phase 1
Clinical Trials (1)
NCT07215923A First in Human Single Ascending Dose (SAD) Study of ATI-1013 in Healthy Smokers
Phase 1Help build intelligence for Antidote Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.